{"id":28,"date":"2024-08-22T17:41:49","date_gmt":"2024-08-22T17:41:49","guid":{"rendered":"http:\/\/b6d.c53.mytemp.website\/home\/?page_id=28"},"modified":"2024-10-28T13:52:21","modified_gmt":"2024-10-28T13:52:21","slug":"projects","status":"publish","type":"page","link":"https:\/\/potentcells.com\/home\/projects\/","title":{"rendered":"Projects"},"content":{"rendered":"

Our projects in immunotherapy gene transfer highlights our experience <\/h2>

in cell & gene therapy. These are the major ones:<\/h2>
<\/div>

Immunotherapy<\/h2>\n\n
\"\"<\/figure>\n\n

Treatment of viral infections using donor-derived cells; viral-specific T cells were generated \u2013 using cells of the donor who initially donated HSCT for the bone marrow transplant \u2013 to protect or treat infections of Adv, CMV, EBV, and BKV. clinicaltrials.gov identifier  NCT02048332<\/a> <\/p>\n\n

Treatment of viral infection using 3rd Party cells; viral-specific T cells were generated using cells of unrelated donor (3rd party) to protect or treat infections of Adv, CMV, EBV, and BKV. clinicaltrials.gov identifier  NCT02532452<\/a><\/p><\/div>\n\n

<\/div>\n\n

Gene Transfer<\/h2>\n\n
\"\"<\/figure>\n\n

Treatment of Sickle cell disease; CD34+<\/sup> patient\u2019 cells transduced with the gamma-globin lentiviral vector then infused back in patient for the correction of sickle cell disease.  clinicaltrials.gov identifier  NCT02186418<\/a><\/p>\n\n

Treatment of Multiple Myeloma; generating autologous Chimeric antigen receptor (CAR) T cells for the treatment of relapse\/refractory (R\/R) multiple myeloma. clinicaltrials.gov identifier  NCT03090659<\/a> <\/p><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Our projects in immunotherapy gene transfer highlights our experience in cell & gene therapy. These are the major ones: Immunotherapy […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ub_ctt_via":"","footnotes":""},"class_list":["post-28","page","type-page","status-publish","hentry"],"featured_image_src":null,"_links":{"self":[{"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/pages\/28"}],"collection":[{"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/comments?post=28"}],"version-history":[{"count":5,"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/pages\/28\/revisions"}],"predecessor-version":[{"id":1127,"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/pages\/28\/revisions\/1127"}],"wp:attachment":[{"href":"https:\/\/potentcells.com\/home\/wp-json\/wp\/v2\/media?parent=28"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}